Citing shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.
Category: Drugs (Pharmaceuticals)
-
States Move to Limit Access to H.I.V. Treatment
The New York Times – Business: -
Why Estrogen Patches For Menopause Are So Hard to Find
The New York Times – Business:Changing attitudes around menopause treatment have driven up demand for hormone therapy.
-
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
The New York Times – Business:Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
-
Vaccine Makers Curtail Research and Cut Jobs
The New York Times – Business:Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
-
Should Drug Companies Be Advertising to Consumers?
The New York Times – Business:Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans.
-
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The New York Times – Business:The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
-
Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers
At two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of medical care for consumers.
-
Weight-Loss Drugs Could Save U.S. Airlines $580 Million Per Year
A study by the financial firm Jefferies highlights a surprising perk for carriers: lower fuel costs as slimmer passengers lighten their aircrafts’ loads.
-
Trump Outlines Health Care Proposals as Prices and Premiums Rise
The long-awaited plan would leave much to Congress and calls for payments to health savings accounts rather than insurance subsidies, among other broad proposals.
-
David Mitchell, Who Led Fight on Drug Prices, Dies at 75
After receiving a diagnosis of terminal cancer, he used his experience in public relations to draw attention to the skyrocketing cost of medication.
-
‘Chinese Peptides’ Are the Latest Biohacking Trend in the Tech World
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.
-
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.